{
    "2019-09-23": [
        [
            {
                "time": "2023-09-15",
                "original_text": "Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Semaglutide",
                        "Tablet",
                        "FDA",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "Lilly Gets CHMP Nod to Add Heart Indication to Trulicity Label",
                "features": {
                    "keywords": [
                        "Lilly",
                        "CHMP",
                        "Heart",
                        "Trulicity"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "Novo Nordisk targets bigger slice of diabetes market with new tablet",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "diabetes",
                        "market",
                        "tablet"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}